Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

about

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Item

http://www.wikidata.org/entity/Q52311573

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@en

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@nl

type

Item

label

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@en

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@nl

prefLabel

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@en

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@nl

P1476

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

@en

P2093

David Cella

http://www.w3.org/2001/XMLSchema#string

Jane S Paulsen

http://www.w3.org/2001/XMLSchema#string

Jin-Shei Lai

http://www.w3.org/2001/XMLSchema#string

Kelvin L Chou

http://www.w3.org/2001/XMLSchema#string

Martha A Nance

http://www.w3.org/2001/XMLSchema#string

Michael K McCormack

http://www.w3.org/2001/XMLSchema#string

Nicholas R Boileau

http://www.w3.org/2001/XMLSchema#string

Noelle E Carlozzi

http://www.w3.org/2001/XMLSchema#string

Praveen Dayalu

http://www.w3.org/2001/XMLSchema#string

P2860

Huntington's disease: a clinical review.

Therapeutic interventions for symptomatic treatment in Huntington's disease

Therapeutic interventions for disease progression in Huntington's disease

A description of sleep behaviour in healthy late pregnancy, and the accuracy of self-reports.

Huntington's disease

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors.

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Challenges assessing clinical endpoints in early Huntington disease.

P2888

s00415-018-8852-5

P31

scholarly article

P356

10.1007/S00415-018-8852-5

http://www.w3.org/2001/XMLSchema#string

P50

Julie C. Stout

Joel S Perlmutter

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29687215

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5992091

http://www.w3.org/2001/XMLSchema#string